Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders

摘要

Corticotropin releasing factor (CRF) antagonists of formula (I):and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.